文献速递艾滋病与性传播感染结核与非结核分枝杆菌新发突发、热带与寄生虫病

卡波西肉瘤相关疱疹病毒对南非住院HIV感染者结核排查期间死亡率的贡献

The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa.
PubMed 文献 · J Infect Dis · 2019-01-01

结果显示,在无结核或其他微生物学确诊合并感染的患者中,高KSHV病毒载量与死亡率相关(调整OR 6.5,95%CI 1.3-32.4),6例疑似KICS患者中5例死亡。

要点

  • 住院HIV感染者中KSHV血清阳性率30.7%,可检测KSHV病毒载量者占5.8%。
  • 无结核或其他确诊合并感染患者中,高KSHV病毒载量与死亡率独立相关。
  • 疑似KICS患者生存率显著更差,提示KSHV VL和KICS标准可指导诊疗评估。

核心结论

  • 在因疑似结核住院的危重HIV感染者中,高KSHV病毒载量与死亡率相关,尤其在无结核或其他微生物学确诊合并感染的患者中。
  • KSHV病毒载量和KICS标准可能指导诊断与治疗评估。

研究设计与样本

  • 评估KSHV血清状态、外周血KSHV病毒载量及KSHV相关临床指标。

主要发现

  • 中位CD4计数为62(范围0-526)cells/μL;KSHV血清阳性率30.7%(95%CI 27%-34%)。
  • 5.8%患者可检测到KSHV病毒载量,中位199.1(范围13.4-2.2×10^6)copies/10^6 cells。
  • 22%患者死亡;在无结核或其他微生物学确诊合并感染的患者(n=159)中,高KSHV病毒载量与死亡率相关(调整OR 6.5,95%CI 1.3-32.4)。
  • 6例患者符合「possible KICS」:5例死亡,生存率显著更差(P < .0001),1例尸检诊断为KSHV相关多中心Castleman病。

临床怎么用

  • 对疑似结核但微生物学未确诊的危重HIV感染者,可考虑检测KSHV病毒载量并评估KICS标准以指导诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite increasing numbers of human immunodeficiency virus (HIV)-infected South Africans receiving antiretroviral therapy (ART), tuberculosis (TB) remains the leading cause of mortality. Approximately 25% of patients treated for TB have microbiologically unconfirmed diagnoses. We assessed whether elevated Kaposi's sarcoma-associated herpesvirus (KSHV) viral load (VL) contributes to mortality in hospitalized HIV-infected patients investigated for TB. METHODS: Six hundred eighty-two HIV-infected patients admitted to Khayelitsha Hospital, South Africa, were recruited, investigated for TB, and followed for 12 weeks. KSHV serostatus, peripheral blood KSHV-VL, and KSHV-associated clinical correlates were evaluated. RESULTS: Median CD4 count was 62 (range, 0-526) cells/μL; KSHV seropositivity was 30.7% (95% confidence interval [CI], 27%-34%); 5.8% had detectable KSHV-VL (median, 199.1 [range, 13.4-2.2 × 106] copies/106 cells); 22% died. Elevated KSHV-VL was associated with mortality (adjusted odds ratio, 6.5 [95% CI, 1.3-32.4]) in patients without TB or other microbiologically confirmed coinfections (n = 159). Six patients had "possible KSHV-inflammatory cytokine syndrome" (KICS): 5 died, representing significantly worse survival (P < .0001), and 1 patient was diagnosed with KSHV-associated multicentric Castleman disease at autopsy. CONCLUSIONS: Given the association of mortality with elevated KSHV-VL in critically ill HIV-infected patients with suspected but not microbiologically confirmed TB, KSHV-VL and KICS criteria may guide diagnostic and therapeutic evaluation.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Blumenthal MJ, Schutz C, Barr D, et al. The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa. J Infect Dis. 2019. PMID: 31004430. doi:10.1093/infdis/jiz180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。